Search

Search Constraints

You searched for: Author/Creator Lahaye, M

Search Results

1. 9PPlasma gene conversions after one cycle (C) abiraterone acetate (AA) for metastatic castration-resistant prostate cancer (mCRPC): A biomarker analysis of a multi-centre, international trial. (7th November 2019)

2. DOP90 Efficacy of the treat-to-target approach in modifying disease course with ustekinumab in patients with moderate-to-severe Crohn's Disease: Results from the STARDUST trial. (21st January 2022)

3. EP1009 Loss of skeletal muscle mass during neo-adjuvant chemotherapy and the relation to survival in patients with ovarian cancer; a prospective analysis of the OVHIPEC-1 cohort. (1st November 2019)

4. OP35 Effect of maintenance ustekinumab on corticosteroid-free endoscopic and clinical outcomes in patients with Crohn's Disease - Week 48 analysis of the STARDUST trial. (27th May 2021)

5. OP40 Analysis of clinical features associated with favourable outcomes from ustekinumab treat-to-target strategy in Crohn's Disease patients in the STARDUST trial. (27th May 2021)

6. P301 Ustekinumab improves health-related quality of life in patients with moderate-to-severe Crohn's disease: results up to Week 48 of the STARDUST trial. (27th May 2021)

7. P495 Perianal fistula closure in patients receiving ustekinumab: Results from the SEAVUE and STARDUST trials. (21st January 2022)